John P Bennett Selected Research

Pyridinolcarbamate (P23)

3/2021

A Comparison of Predicted Ipsilateral Tumor Recurrence Risks in Patients With Ductal Carcinoma in Situ of the Breast After Breast-Conserving Surgery by Breast Radiation Oncologists, the Van Nuys Prognostic Index, the Memorial Sloan Kettering Cancer Center DCIS Nomogram, and the 12-Gene DCIS Score Assay.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John P Bennett Research Topics

Disease

2	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2021 - 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Prostatic Neoplasms (Prostate Cancer) 01/2023
1	Neoplasms (Cancer) 03/2021

Drug/Important Bio-Agent (IBA)

1	Indicators and Reagents (Reagents)IBA 01/2023
1	Pyridinolcarbamate (P23)IBA 03/2021

Therapy/Procedure

2	Radiotherapy 01/2023 - 01/2021
1	Prostatectomy (Retropubic Prostatectomy) 01/2023
1	Segmental Mastectomy (Lumpectomy) 03/2021